App-Based therapy aims to slow down paranoia in psychosis

NCT ID NCT06568081

Recruiting now Symptom relief Sponsor: King's College London Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 2 times

Summary

This study tests SloMo, a digital therapy that helps people with psychosis who fear harm from others. It combines face-to-face sessions with a mobile app to help users notice worries and slow down fast thinking. 150 participants across three NHS trusts will try the therapy, with researchers measuring safety, engagement, and changes in paranoia and wellbeing over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SloMo (digitally supported cognitive-behavioural therapy)
What this could lead to: If it works, this could make effective therapy for paranoia more widely available in the NHS.
What could go wrong: This is a small, early-stage implementation study (150 people) in routine care, not a large efficacy trial. Results may not generalize, and technical or engagement issues could limit success.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AFFECTIVE PSYCHOSES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Affective Disorders, Psychotic bipolar disorder psychotic disorder Schizophrenia Spectrum and Other Psychotic Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AFFECTIVE PSYCHOSES SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS

Contacts and locations

Locations

South London and Maudsley NHS Foundation Trust
RECRUITING

London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.